Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice.
Eur J Nucl Med Mol Imaging
; 47(10): 2358-2371, 2020 09.
Article
in En
| MEDLINE
| ID: mdl-32062681
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neuroendocrine Tumors
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Eur J Nucl Med Mol Imaging
Journal subject:
MEDICINA NUCLEAR
Year:
2020
Document type:
Article
Affiliation country:
Germany
Country of publication:
Germany